Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis. | Sci Rep | 2022 | 36494415 | PubTator, text mining | PubMed |
| Comprehensive analysis of the relationship between cuproptosis-related genes and esophageal cancer prognosis. | World J Clin Cases | 2022 | 36483804 | PubTator, text mining | PubMed |
| Immunomodulatory regulator blockade in a viral exacerbation model of severe asthma. | Front Immunol | 2022 | 36479132 | PubTator, text mining | PubMed |
| Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy. | Front Immunol | 2022 | 36479115 | PubTator, text mining | PubMed |
| Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-γ response in early phase of viral infection. | Nat Commun | 2022 | 36477661 | PubTator, text mining | PubMed |
| Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 36470669 | PubTator, text mining | PubMed |
| Prognostic value of PNN in prostate cancer and its correlation with therapeutic significance. | Front Genet | 2022 | 36468018 | PubTator, text mining | PubMed |
| Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation. | Front Immunol | 2022 | 36466912 | PubTator, text mining | PubMed |
| The immunosuppressive microenvironment and immunotherapy in human glioblastoma. | Front Immunol | 2022 | 36466873 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient. | Front Immunol | 2022 | 36466840 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer. | Front Immunol | 2022 | 36466815 | PubTator, text mining | PubMed |
| Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges. | Aging Dis | 2022 | 36465180 | PubTator, text mining | PubMed |
| Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers. | Commun Biol | 2022 | 36463330 | PubTator, text mining | PubMed |
| Multiset multicover methods for discriminative marker selection. | Cell Rep Methods | 2022 | 36452867 | PubTator, text mining | PubMed |
| Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. | Front Immunol | 2022 | 36451813 | PubTator, text mining | PubMed |
| Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. | Nature | 2022 | 36450981 | PubTator, text mining | PubMed |
| Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection. | Clin Transl Med | 2022 | 36447039 | PubTator, text mining | PubMed |
| System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer. | Aging (Albany NY) | 2022 | 36445321 | PubTator, text mining | PubMed |
| Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. | Nat Commun | 2022 | 36443294 | PubTator, text mining | PubMed |
| Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification. | EBioMedicine | 2022 | 36442320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=42